Comparison of efficacy and safety of Rituximab (MabtheraTM) and its biosimilar (RedituxTM) in diffuse large B-cell lymphoma (DLBCL) patients treated with chemo-immunotherapy: a retrospective analysis
By: Roy, Partha Sarathi.
Material type:
Item type | Current location | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|
![]() |
Tata Memorial Hospital | ROY/NAI | Available | TH705 |
DM HBNI Nair, Reena 2010
CD only
There are no comments for this item.